Cell Death and Disease Journal Citation Rate 2026
2041-4889
Springer Nature
GB
Open Access
About Cell Death and Disease
Cell Death and Disease (CDD) is an academic journal covering Autophagy in Disease and Therapy and Cancer-related molecular mechanisms research, published by Springer Nature in GB, catalogued under ISSN 2041-4889. It is fully open access. OpenAlex records 12,208 works and 601,627 citations, with an h-index of 237.
Authors typically receive a first decision in around 67 days.
Submission Tips for Cell Death and Disease
- Be prepared for a longer review cycle — decisions typically take around 67 days.
- This journal covers Autophagy in Disease and Therapy, Cancer-related molecular mechanisms research, Epigenetics and DNA Methylation. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cell Death and … Compares
Compared against 47 journals in the same research areas.
| ISSN (Print) | 2041-4889 |
|---|---|
| Publisher | Springer Nature |
| Country | United Kingdom |
| APC / Cost | Inquire with Publisher |
| Review Speed | ~67 days to first decision |
| h-index | 250 |
| Total Works | 12,490 |
| Total Citations | 660,593 |
| 2-yr Mean Citedness | 12.88 (OpenAlex) |
| DOAJ | Listed |
In-depth profile & metrics
Cell Death and Disease is published by Springer Nature and based in United Kingdom. It publishes on an open-access basis.
In our subject taxonomy, Cell Death and Disease is classified under Autophagy in Disease and Therapy, Cancer-related molecular mechanisms research, Epigenetics and DNA Methylation and MicroRNA in disease regulation.
Cell Death and Disease is indexed in the DOAJ and OpenAlex. DOAJ lists the journal as open access.
For prospective authors, Cell Death and Disease returns a first decision in about 67 days (longer for its field).
OpenAlex records 12,490 works that have together drawn 660,593 citations, giving the journal an h-index of 250; OpenAlex puts its two-year mean citedness at 12.88.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Cell Death and Disease
OpenAlex and DOAJ Coverage
Updated March 2026OpenAlex and DOAJ coverage we hold for this journal. Check other databases at the source.
Citation Rate
No citation rate data available.
Metrics are sourced from OpenAlex and DOAJ and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Works Published per Year (2014–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Publication & citation history by year
| Year | Works published | Citations received |
|---|---|---|
| 2025 | 1,031 | 98,294 |
| 2024 | 933 | 90,761 |
| 2023 | 852 | 76,187 |
| 2022 | 1,045 | 71,886 |
| 2021 | 1,193 | 65,221 |
| 2020 | 1,074 | 48,438 |
| 2019 | 956 | 32,424 |
| 2018 | 1,207 | 24,135 |
| 2017 | 657 | 18,180 |
| 2016 | 468 | 14,901 |
| 2015 | 425 | 11,780 |
| 2014 | 604 | 7,796 |
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where Cell Death and Disease most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.
Journal Metrics
Research Highlights
Recently published high-impact papers in this journal:
-
Proteasomal-dependent CHK1 degradation leads to DNA damage accumulation in ALS cellular model systems
Stefania Modafferi, Valentina Silenzi, Anna Garbelli • 2026
Compare Journals
Compare Cell Death and Disease against similar publications in its field:
Related Journals in Your Field
-
Journal of Experimental & Clinical Cancer Research BioMed Central IF 10.31
-
Theranostics Ivyspring International Publisher IF 10.23
-
Cancer Letters Elsevier BV IF 8.60
-
EBioMedicine Elsevier BV IF 8.28
-
Biomedicine & Pharmacotherapy Elsevier BV IF 7.27
Explore More Journals
Metadata
Last updated: Mar 20, 2026
Updated by: system
Get weekly updates for Autophagy in Disease and Therapy journals
Free. Monday morning. New citation rates, CFPs, updates on journals you track, predatory watch list. One-click unsubscribe.